Subramani S, Kanthakumar P, Maneksh D, Sidharthan A, Rao SV, Parasuraman V, Tharion E. O2-CO2 diagram as a tool for comprehension of blood gas abnormalities. Adv Physiol Educ. 2011 Sep;35(3):314-20. doi: 10.1152/advan.00110.2010. PMID: 21908843.

Shalini Anandan, Lydia Jennifer, Agila Kumari Pragasam, Baby Abirami Shankar, Balaji Veeraraghavan, John Victor Peter and Shoma V Rao. Synergy Testing between Sulbactam and Meropenem/ Colistin in MDR Acinetobacter baumannii-calcoaceticus Complex Isolated from Ventilator Associated Pneumonia. Journal of Infectious Disease and Therapy.2016; 4:299. doi:10.4172/2332-0877.1000299

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. doi: 10.1002/jcph.2130. Epub 2022 Aug 24. PMID: 35924629.

Manesh A, Shankar C, George MM, Jasrotia DS, Lal B, George B, Mathews V, Eapen CE, Joseph P, Subramani K, Rao S, Peter JV, Chacko B, Zachariah A, Sathyendra S, Hansdak SG, Abraham OC, Iyadurai R, Vijayakumar S, Karthik R, Marwick CA, Parcell BJ, Gilbert IH, Veeraraghavan B, Varghese GM. Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort Study. Infect Dis Ther. 2023 May;12(5):1319-1335. doi: 10.1007/s40121-023-00803-3. Epub 2023 Apr 16. PMID: 37062023; PMCID: PMC10229510.

Yamuna Devi Bakthavatchalam, Karthick Vasudevan, ShomaVinay Rao, Santosh Varughese, Priscilla Rupali, Maki Gina, Marcus Zervos, John Victor Peter, Balaji Veeraraghavan, Genomic portrait of community-associated methicillin-resistant Staphylococcus aureus ST772-SCCmec V lineage from India, Gene Reports, Volume 24, 2021, 101235, ISSN 2452-0144, https://doi.org/10.1016/j.genrep.2021.101235. https://www.sciencedirect.com/science/article/pii/S245201442100220X)

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. Link

Subramani S, Kanthakumar P, Maneksh D, Sidharthan A, Rao SV, Parasuraman V, Tharion E. O2-CO2 diagram as a tool for comprehension of blood gas abnormalities. Adv Physiol Educ. 2011 Sep;35(3):314-20. doi: 10.1152/advan.00110.2010. PMID: 21908843.

Shalini Anandan, Lydia Jennifer, Agila Kumari Pragasam, Baby Abirami Shankar, Balaji Veeraraghavan, John Victor Peter and Shoma V Rao. Synergy Testing between Sulbactam and Meropenem/ Colistin in MDR Acinetobacter baumannii-calcoaceticus Complex Isolated from Ventilator Associated Pneumonia. Journal of Infectious Disease and Therapy.2016; 4:299. doi:10.4172/2332-0877.1000299

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. doi: 10.1002/jcph.2130. Epub 2022 Aug 24. PMID: 35924629.

Manesh A, Shankar C, George MM, Jasrotia DS, Lal B, George B, Mathews V, Eapen CE, Joseph P, Subramani K, Rao S, Peter JV, Chacko B, Zachariah A, Sathyendra S, Hansdak SG, Abraham OC, Iyadurai R, Vijayakumar S, Karthik R, Marwick CA, Parcell BJ, Gilbert IH, Veeraraghavan B, Varghese GM. Clinical and Genomic Evolution of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections over Two Time Periods at a Tertiary Care Hospital in South India: A Prospective Cohort Study. Infect Dis Ther. 2023 May;12(5):1319-1335. doi: 10.1007/s40121-023-00803-3. Epub 2023 Apr 16. PMID: 37062023; PMCID: PMC10229510.

Yamuna Devi Bakthavatchalam, Karthick Vasudevan, ShomaVinay Rao, Santosh Varughese, Priscilla Rupali, Maki Gina, Marcus Zervos, John Victor Peter, Balaji Veeraraghavan, Genomic portrait of community-associated methicillin-resistant Staphylococcus aureus ST772-SCCmec V lineage from India, Gene Reports, Volume 24, 2021, 101235, ISSN 2452-0144, https://doi.org/10.1016/j.genrep.2021.101235. https://www.sciencedirect.com/science/article/pii/S245201442100220X)

Mathew SK, Rao SV, Prabha R, Neely MN, Mathew BS, Aruldhas BW, Veeraraghavan B, Kandasamy S. Model-Informed Rationale for Early Therapeutic Drug Monitoring of Colistin in Critically Ill Patients. J Clin Pharmacol. 2023 Jan;63(1):57-65. Link

Bakthavatchalam YD, Rao SV, Isaac B, Manesh A, Nambi S, Swaminathan S, Nagvekar V, Nangia V, John PV, Veeraraghavan B. A comparative assessment of clinical, pharmacological and antimicrobial profile of novel anti-methicillin-resistant Staphylococcus aureus agent levonadifloxacin: Therapeutic role in nosocomial and community infections. Indian J Med Microbiol. 2019 Oct-Dec;37(4):478-487. doi: 10.4103/ijmm.IJMM_20_34. PMID: 32436868.

Rao SV, Jacob GG, Raju NA, Ancheri SA. Spontaneous arterial hemorrhage as a complication of dengue. Indian J Crit Care Med. 2016 May;20(5):302-4. doi: 10.4103/0972-5229.182201. PMID: 27275081; PMCID: PMC4876654.

Mathew, Sumith K et al. “Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity.” Clinical and translational science vol. 17,3 (2024): e13764. doi:10.1111/cts.13764